Clinical characteristics | Value |
---|---|
Age at study visit, years, median (IQR) | 13.9 (11.3–15.1) |
Age at disease onset, years, median (IQR) | 8.4 (2.7–11.1) |
Disease duration, years, median (IQR) | 4.8 (2.8–8.3) |
JIA categorya, n (%) | |
Oligoarticular persistent | 15 (35.7) |
Oligoarticular extended | 3 (7.1) |
Polyarticular RF negative | 10 (23.8) |
Psoriatic | 2 (4.8) |
Enthesitis-related | 8 (19.0) |
Undifferentiated | 4 (9.5) |
ANA positiveb, n (%) | 14 (35.0) |
HLA-B27 positive, n (%) | 13 (31.0) |
Disease activityc, n (%) | |
Remission off medication | 12 (28.6) |
Inactive | 9 (21.4) |
Active | 21 (50.0) |
JADAS71d > 0, n (%) | 28 (70.0) |
PhysGA VAS > 0, n (%) | 14 (33.3) |
Number of individuals with active jointse, n (%) | 9 (21.4) |
DMARDsf ongoing, n (%) | 24 (57.1) |
Steroids ongoing, n (%) | 2 (4.7) |
NSAIDs ongoing, n (%) | 15 (35.7) |
No medication, n (%) | 13 (31.0) |